November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs. However, an unexpected finding made by a team of University of California…
November 3, 2022
This season there are three prevalent respiratory viruses to be aware of—influenza, SARS-CoV-2 and respiratory syncytial virus (RSV), all of which are transmitted via aerosols.
March 24, 2020
Rice University researchers used the Comet supercomputer at SDSC to evaluate their new molecular docking too to help improve cancer immunotherapy outcomes by identifying more effective personalized treatments.
April 9, 2013
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
September 16, 2016
…Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe Biden.
September 3, 2019
CARB-X, an international funder of efforts to fight antimicrobial resistance, is awarding up to $15 million to develop a strep throat vaccine based on original research at UC San Diego.
October 18, 2022
Victor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine.
September 27, 2012
An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for…
August 13, 2019
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.
June 18, 2020
…infection-fighting cells of the immune system, he began a nationwide search for treatment that led him to Edward D. Ball, M.D. at Moores Cancer Center at UC San Diego Health. “I was fortunate to have been referred to Dr. Ball, a prominent hematologist-oncologist and director of the Blood and Marrow…
